148 related articles for article (PubMed ID: 17083980)
1. A high throughput fluorescent assay for measuring the activity of fatty acid amide hydrolase.
Kage KL; Richardson PL; Traphagen L; Severin J; Pereda-Lopez A; Lubben T; Davis-Taber R; Vos MH; Bartley D; Walter K; Harlan J; Solomon L; Warrior U; Holzman TF; Faltynek C; Surowy CS; Scott VE
J Neurosci Methods; 2007 Mar; 161(1):47-54. PubMed ID: 17083980
[TBL] [Abstract][Full Text] [Related]
2. A fluorescence-based assay for fatty acid amide hydrolase compatible with high-throughput screening.
Ramarao MK; Murphy EA; Shen MW; Wang Y; Bushell KN; Huang N; Pan N; Williams C; Clark JD
Anal Biochem; 2005 Aug; 343(1):143-51. PubMed ID: 16018870
[TBL] [Abstract][Full Text] [Related]
3. High-throughput screening for the discovery of inhibitors of fatty acid amide hydrolase using a microsome-based fluorescent assay.
Wang Y; Ramirez F; Krishnamurthy G; Gilbert A; Kadakia N; Xu J; Kalgaonkar G; Ramarao MK; Edris W; Rogers KE; Jones PG
J Biomol Screen; 2006 Aug; 11(5):519-27. PubMed ID: 16760367
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets.
Zhang D; Saraf A; Kolasa T; Bhatia P; Zheng GZ; Patel M; Lannoye GS; Richardson P; Stewart A; Rogers JC; Brioni JD; Surowy CS
Neuropharmacology; 2007 Mar; 52(4):1095-105. PubMed ID: 17217969
[TBL] [Abstract][Full Text] [Related]
5. Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
Vincent F; Nguyen MT; Emerling DE; Kelly MG; Duncton MA
Bioorg Med Chem Lett; 2009 Dec; 19(23):6793-6. PubMed ID: 19850474
[TBL] [Abstract][Full Text] [Related]
6. Development of highly sensitive fluorescent assays for fatty acid amide hydrolase.
Huang H; Nishi K; Tsai HJ; Hammock BD
Anal Biochem; 2007 Apr; 363(1):12-21. PubMed ID: 17291440
[TBL] [Abstract][Full Text] [Related]
7. A MBP-FAAH fusion protein as a tool to produce human and rat fatty acid amide hydrolase: expression and pharmacological comparison.
Labar G; Vliet FV; Wouters J; Lambert DM
Amino Acids; 2008 Jan; 34(1):127-33. PubMed ID: 17476568
[TBL] [Abstract][Full Text] [Related]
8. Rapid screening for potentially relevant polymorphisms in the human fatty acid amide hydrolase gene using Pyrosequencing.
Doehring A; Geisslinger G; Lötsch J
Prostaglandins Other Lipid Mediat; 2007 Nov; 84(3-4):128-37. PubMed ID: 17991615
[TBL] [Abstract][Full Text] [Related]
9. A fluorescent assay suitable for inhibitor screening and vanin tissue quantification.
Ruan BH; Cole DC; Wu P; Quazi A; Page K; Wright JF; Huang N; Stock JR; Nocka K; Aulabaugh A; Krykbaev R; Fitz LJ; Wolfman NM; Fleming ML
Anal Biochem; 2010 Apr; 399(2):284-92. PubMed ID: 20018163
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and in vitro evaluation of carbamate derivatives of 2-benzoxazolyl- and 2-benzothiazolyl-(3-hydroxyphenyl)-methanones as novel fatty acid amide hydrolase inhibitors.
Myllymäki MJ; Saario SM; Kataja AO; Castillo-Melendez JA; Nevalainen T; Juvonen RO; Järvinen T; Koskinen AM
J Med Chem; 2007 Aug; 50(17):4236-42. PubMed ID: 17665899
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system.
Fezza F; De Simone C; Amadio D; Maccarrone M
Subcell Biochem; 2008; 49():101-32. PubMed ID: 18751909
[TBL] [Abstract][Full Text] [Related]
12. Characterization of fatty acid amide hydrolase activity by a fluorescence-based assay.
Dato FM; Maaßen A; Goldfuß B; Pietsch M
Anal Biochem; 2018 Apr; 546():50-57. PubMed ID: 29408178
[TBL] [Abstract][Full Text] [Related]
13. Vanilloid receptor 1 (TRPV1/VR1) co-localizes with fatty acid amide hydrolase (FAAH) in retinal amacrine cells.
Zimov S; Yazulla S
Vis Neurosci; 2007; 24(4):581-91. PubMed ID: 17686199
[TBL] [Abstract][Full Text] [Related]
14. A sensitive and specific radiochromatographic assay of fatty acid amide hydrolase activity.
Maccarrone M; Bari M; Agrò AF
Anal Biochem; 1999 Feb; 267(2):314-8. PubMed ID: 10036136
[TBL] [Abstract][Full Text] [Related]
15. Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.
Mor M; Rivara S; Lodola A; Plazzi PV; Tarzia G; Duranti A; Tontini A; Piersanti G; Kathuria S; Piomelli D
J Med Chem; 2004 Oct; 47(21):4998-5008. PubMed ID: 15456244
[TBL] [Abstract][Full Text] [Related]
16. Fluorimetric Assay of FAAH Activity.
Angelucci CB; Giacominelli-Stuffler R; Maccarrone M
Methods Mol Biol; 2023; 2576():249-260. PubMed ID: 36152193
[TBL] [Abstract][Full Text] [Related]
17. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 2. Discovery of 7-azaspiro[3.5]nonane urea PF-04862853, an orally efficacious inhibitor of fatty acid amide hydrolase (FAAH) for pain.
Meyers MJ; Long SA; Pelc MJ; Wang JL; Bowen SJ; Schweitzer BA; Wilcox MV; McDonald J; Smith SE; Foltin S; Rumsey J; Yang YS; Walker MC; Kamtekar S; Beidler D; Thorarensen A
Bioorg Med Chem Lett; 2011 Nov; 21(21):6545-53. PubMed ID: 21924613
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoid system in first trimester placenta: low FAAH and high CB1 expression characterize spontaneous miscarriage.
Trabucco E; Acone G; Marenna A; Pierantoni R; Cacciola G; Chioccarelli T; Mackie K; Fasano S; Colacurci N; Meccariello R; Cobellis G; Cobellis L
Placenta; 2009 Jun; 30(6):516-22. PubMed ID: 19419760
[TBL] [Abstract][Full Text] [Related]
20. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.
Russo R; Loverme J; La Rana G; Compton TR; Parrott J; Duranti A; Tontini A; Mor M; Tarzia G; Calignano A; Piomelli D
J Pharmacol Exp Ther; 2007 Jul; 322(1):236-42. PubMed ID: 17412883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
